We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Scythian Biosciences Corp | TSXV:SCYB | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
Grit Updates the Market on Recent Corporate Initiatives & Milestones
|
“Cannabis and crypto are two of the most booming growth sectors in North America. Billions of dollars of capital are being invested into these industries with increasing institutional backing. Grit Capital prides itself on showcasing the right companies to the right people, in immersive settings where “fun” and “informative” intersect, driving strong investor engagement.” said Genevieve Roch-Decter, CEO of Grit Capital.
The conference will feature 20 of the most exciting crypto, cannabis, gaming & healthtech companies in North America. Including: Einstein Exchange (private), HyperBlock Technologies Corp. (soon to be public), LiveWell Canada Corp. (LVWL-V), Namaste Technologies (N-V), Akumin Inc. (AKU.U-T), Enthusiast Gaming (soon to be public), High Hampton Holdings (HC-CSE), Fortress Blockchain Corp. (soon to be public), MediPharm Labs (soon to be public), Liberty Health Sciences Inc. (LHS-CSE), Scythian Biosciences Corp. (SCYB-V) and International Cannabis Corp (ICC-V).
The conference will feature +50 international wealth managers, 1x1 company circuit, immersive games and competitions, unique skill building in personal cyber security, presenting with flair, tricks of the trade tax planning, live pyrotechnics entertainment and much more.
Media star participants will include Todd Shapiro, host of the Todd Shapiro Show on SiriusXM Canada Laughs channel 168 with approximately 1 million weekly listeners and YouTube sensation Michael McCrudden with 2.4M subscribers and over 600 million views. Stockhouse, Grit Capital’s new Media Partner will also be at GritCAMP. They have over 1 million unique visitors a month, are Canada’s #1 financial portal and one of North America’s largest small cap investor communities.
Speakers will include Matthew Nordgren, a top cannabis investor and principle at Arcadian Funds who has managed over $7 billion in transactions and assets, Joey Farrell, CMT #2 ranked technical analyst in Canada by Brendan Wood International Survey (2014) and Dominic Vogel, Chief Strategist at CyberSC, who holds a proven track record within cyber security across a multitude of industries.
To learn more about GritCAMP, the crypto & cannabis markets and investments please watch Grit Capital’s co-CEO’s Genevieve Roch-Decter & Nicole Marchand featured on Bloomberg-BNN’s Market Call Tuesday, June 19th 2018.
Grit Updates the Market on Recent Corporate Initiatives & Milestones
ABOUT GRIT CAPITAL Grit Capital is a capital markets advisory firm based in Toronto, Canada. In a nutshell: We “Tell the Right Story to the Right People” and “Incessantly Chase ROI”. We showcase our clients to investors through targeted 1x1 meetings, events, conferences, cross-north America roadshows and on social media. We pride ourselves on “out of the box” thinking to captivate mindshare. The intersection of “fun” and “informative” is where we and our clients thrive. We control our own messaging through our media platform, GritMedia, featuring a weekly newsletter, BlockTalk, that goes out to ~2k curated finance professionals, YouTube channel, and conference series. We currently have over 10k high quality followers such as portfolio managers, retail advisors and accredited investors.
For further information, please visit our corporate website at www.gritcapital.ca as well as on both Instagram: @gritcapital
Genevieve Roch-Decter, CFA, CEOgdecter@gritcapital.ca
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/84c4b0bb-4610-477a-894b-c894689e8bc5
1 Year Scythian Biosciences Corp Chart |
1 Month Scythian Biosciences Corp Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions